Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CFD RESEARCH CORPORATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2023-06-12 to 2024-06-30
Current total value of award: $179898
Description: FDABAA-22-00123 - PMQWP  374 - A CFD-PBPK FRAMEWORK FOR SUPPORTING BIOEQUIVALENCE EVALUATION OF OPHTHALMIC DRUGS